Our Visual Brain
Our Visual Brain is a clinician-guided web-based vision therapy platform serving optometrists, vision therapists, and rehabilitation specialists treating amblyopia, concussion, neurodivergent, reading, and sports vision conditions, sold via subscription with a free trial.
- Company typePrivate
- Founded2017
- HeadquartersGig Harbor, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Our Visual Brain does
Our Visual Brain (OVB) is a clinician-guided vision therapy platform founded in 2017 and headquartered in Gig Harbor, Washington. The company serves optometrists, vision therapists, concussion specialists, and rehabilitation clinicians who treat patients with amblyopia, strabismus, binocular vision disorders, post-concussion visual deficits, neurodivergent profiles (including ADHD and autism spectrum), reading and academic difficulties, and sports vision needs. OVB is positioned as a unified platform that supports the full therapy arc from early skill development through functional carryover, with the explicit goal of eliminating the need for clinicians to switch between multiple tools across stages of treatment.
The platform is delivered as a cloud-based web application accessible across Windows, macOS, Linux, Chrome OS, Android, iOS, and iPadOS via modern browsers (Firefox 125+, Chrome 87+, Edge 87+, Safari 15.4+) and requires WebGL support. Core features include structured skill progression from early acquisition to real-world use, clinician-guided adaptation in which therapy demand adjusts as patients progress, and intentional activity variety to sustain engagement. The platform integrates therapy activities, videos, worksheets, and protocols within a single system, and the activity library is updated regularly across age groups and skill levels. Every activity is developed with direct input from Vision Therapists and Doctors and is reviewed by an Advisory Panel before release to ensure compliance with current therapeutic standards.
OVB operates a sales-led go-to-market targeting individual eye care practices and rehabilitation clinics, with a free trial entry point to support clinician evaluation and conversion to a paid subscription. The company is privately held as an LLC with 1-10 employees, and the source material discloses no external funding rounds, no M&A activity, and no leadership changes. Advisory Panel members including Dr. Ryan Capouch (OD FCOVD), Dr. Robyn Rakov, Dr. Carolanne Roach, Lisa Knopp, and Tiffany Tarbe provide clinical validation and serve as credibility assets for clinician acquisition.
Our Visual Brain firmographics
Firmographics- Name
- Our Visual Brain
- Legal name
- Our Visual Brain LLC
- Website
- https://ourvisualbrain.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Our Visual Brain is a clinician-guided web-based vision therapy platform serving optometrists, vision therapists, and rehabilitation specialists treating amblyopia, concussion, neurodivergent, reading, and sports vision conditions, sold via subscription with a free trial.
- Ownership category
- akta.pro rank
Our Visual Brain industry classification
Industry- Product category
- Vision Therapy Software
- SIC
- Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment) (HLAHAJAM)
- akta.pro secondary industry
- Neuro-Ophthalmology (HLAKAKAH)
Keywords
Where Our Visual Brain is headquartered
LocationHeadquarters
- HQ city
- Gig Harbor
- HQ country
- United States
- HQ region
- North America
Markets served
Our Visual Brain business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Platform Subscription (Implied): The platform offers different plans (Plans page referenced) suggesting a subscription-based revenue model for clinical practices. The free trial mention indicates a conversion funnel from trial to paid subscription.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free Trial |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Our Visual Brain product offering
Product offeringCore offering
Our Visual Brain (OVB) is a clinician-guided, web-based vision therapy platform that supports patients across the full therapy arc—from early skill acquisition through functional carryover. It delivers structured skill progression, clinician-guided adaptation, gamified therapy activities, and integrated resources (videos, worksheets, protocols) for treating amblyopia, strabismus, concussion-related visual deficits, neurodivergent profiles, reading challenges, and sports vision applications.
Product overview
Our Visual Brain (OVB) is a single unified vision therapy platform designed for clinicians to guide patients through the full therapy arc. The platform provides structured skill progression from early acquisition to real-world use, integrating therapy activities, videos, worksheets, and protocols within one consistent system. OVB supports diverse clinical cases including amblyopia, strabismus, neuro-rehabilitation, neurodivergent profiles, reading challenges, and sports vision applications, serving pediatric through adult patients.
Differentiator
Problem solved
Functional benefit
Products and services
- Our Visual Brain (OVB) Platform Clinician-guided, web-based vision therapy platform supporting the full therapy arc—from early skill acquisition through functional carryover. Includes structured skill progression, clinician-guided adaptation, gamified therapy activities, and integrated resources (videos, worksheets, protocols). Used by eye care professionals to treat amblyopia, strabismus, concussion-related visual deficits, neurodivergent profiles, reading challenges, and sports vision applications.
Quantifiable outcome
- Compliance is way up because patients are engaged — 'They weren't having fun before and now they are.' (Dr. Ryan Capouch)
Companies that use Our Visual Brain
Customer profileNamed customers1 record
Segments7 records
Ideal customer profiles1 record
Our Visual Brain technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Our Visual Brain partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights4 records
Our Visual Brain competitors and assessment
Company assessmentBroad incumbents
- RightEye: RightEye provides eye-tracking-based vision performance and assessment tools used by optometrists, sports performance, and concussion specialists. Overlaps with OVB on sports vision and concussion-rehab use cases within the same clinician buyer set.
Emerging players
- SyncThink: SyncThink offers FDA-cleared eye-tracking-based assessment for concussion/brain injury, used by clinicians and sports organizations. Adjacent to OVB's neuro-rehabilitation use case and shares concussion-specialist buyers.
- Bynocs: Bynocs is a cloud-based dichoptic vision therapy software for amblyopia and binocular disorders, sold to eye-care practices. Comparable platform model to OVB but primarily serving the India/Southeast Asia region.
Direct peers
- HTS (Home Therapy Solutions): HTS provides home-based vision therapy software and kits prescribed by optometrists, focused on convergence, amblyopia, and binocular vision exercises. Directly comparable clinician-to-patient therapy software business.
- Luminopia: Luminopia is an FDA-cleared digital therapeutic for amblyopia delivered via headset, sold to ophthalmologists and optometrists. Directly comparable to OVB's amblyopia/strabismus indication and clinician-purchaser model, with the addition of regulatory clearance.
- NovaSight (CureSight): NovaSight develops digital vision care technologies including the CureSight amblyopia therapy system, sold to eye-care professionals. Overlaps with OVB on clinician-guided digital amblyopia therapy and shares the optometry buyer.
- Vivid Vision: Vivid Vision is a clinician-delivered vision therapy platform using VR-based exercises for amblyopia, strabismus, and binocular vision disorders—the same core use cases and clinician buyer (optometrists/VT clinics) as Our Visual Brain.
- AmblyoPlay: AmblyoPlay offers gamified vision therapy software for amblyopia and binocular disorders, sold to parents and clinicians via subscription. Closely comparable to OVB's gamified, clinician-and-home vision therapy model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Our Visual Brain social profiles
Digital presenceOur Visual Brain financial estimates
Financial estimateRevenue estimate
Valuation estimate
Our Visual Brain leadership team
Management profileNumber of profiles
Our Visual Brain funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Our Visual Brain M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Our Visual Brain
What does Our Visual Brain do?
Our Visual Brain (OVB) is a clinician-guided, web-based vision therapy platform that supports patients across the full therapy arc—from early skill acquisition through functional carryover. It delivers structured skill progression, clinician-guided adaptation, gamified therapy activities, and integrated resources (videos, worksheets, protocols) for treating amblyopia, strabismus, concussion-related visual deficits, neurodivergent profiles, reading challenges, and sports vision applications.
Is Our Visual Brain a public or private company?
Our Visual Brain is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Our Visual Brain founded?
Our Visual Brain was founded in 2017. It employs 1 to 10 people.
Where is Our Visual Brain based?
Our Visual Brain is headquartered in Gig Harbor, United States, in the North America region.
How does Our Visual Brain make money?
One revenue line is on record: platform Subscription (Implied).
Who are Our Visual Brain's main competitors?
RightEye is listed as a broad incumbent. Emerging players are SyncThink and Bynocs. Direct peers are HTS (Home Therapy Solutions), Luminopia, NovaSight (CureSight), Vivid Vision and AmblyoPlay.
Does Our Visual Brain have an API?
No public API is recorded for Our Visual Brain.
What industry is Our Visual Brain in?
Our Visual Brain's product category is Vision Therapy Software. Its primary akta.pro industry code is HLAHAJAM, Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment), with a secondary code of HLAKAKAH, Neuro-Ophthalmology. Its SIC code is 7373.